Replies to post #1249 on Vascular Biogenics Ltd (VBLT)

[davidal66]

VBLT could run big here without news as well. Biotech is looking more than just fine lately. Take a look at AXON. Coming up on a big binary with a phase III for Alzheimer's which I think does not work, or works in the most tepid fashion. AXON bought there phase III drug from a big pharma for peanuts 5-10 million dollars. Why do I bring up this example? The market cap of AXON is well over 2 billion dollars... for smoke and mirrors. VBLT has ore interesting/innovative tech in a phase III program with a market cap of under 200 million or so. The only difference is the CEO of AXON is beloved on wall street; while Dror is an outsider. For a bet on technology, I would much rather play the biotech roulette table with VBLT than AXON. Sorry to get off topic. But I do get a big disgusted with all of the news reports on AXON; while ignoring the VBLT story; but that could change in a snap.

[mjw007]

Not sure what the catalyst is ..... but let's enjoy the ride !
Hopefully we are just getting started !

[staccani]

If you read my previous posts you will understand what is going on. Many Signs pointing to a successful gbm ph3 result. Basically many know already how the trial is going; doctors and patients (as they are not blinded), DSMC, and i guess insiders as well ( they would just need to ask doctors or patients). The recent Lee family buy is another sign together with trial being now at avg 14 months treatment duration, the much quicker full Enrolment of gbm ph3 , company planning to open a mfg site to produce VB111 in large quantities and starting another ph3 both in q4. What else do we need to know (other than the official ph3 results)?

[Oren1976]

I believe the rise is not connected as u said to the ph3